Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (307)

51

Comparison of the characteristics, morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy: a retrospective cohort study

enthalten in: Internal and emergency medicine | 2022

von Leidi, F. | Boari, G. | Scarano, O. | +21

52

Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study

enthalten in: Infection | 2022

von Oliva, A. | Curtolo, A. | Volpicelli, L. | +10

53

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

enthalten in: Annals of hematology | 2022

von Piñana, J. | Rodríguez-Belenguer, P. | Caballero, D. | +29

54

Update on the Management of Pediatric Psoriasis: An Italian Consensus

enthalten in: Dermatology and therapy | 2022

von Peris, K. | Fortina, A. | Bianchi, L. | +27

55

Multisystem Inflammatory Syndrome Associated With COVID-19 in Children (MIS-C): A Systematic Review of Studies From India

enthalten in: Indian pediatrics | 2022

von Sachdeva, M. | Agarwal, A. | Sra, H. | +5

56

Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

enthalten in: Intensive care medicine | 2022

von Torres, A. | Motos, A. | Cillóniz, C. | +65

57

Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19

enthalten in: Rheumatology and therapy | 2022

von Boggio, F. | Ciavarella, A. | Arcudi, S. | +5

58

Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels

enthalten in: Immunologic research | 2022

von Dobi, A. | Dubernet, A. | Rakoto, M. | +5

59

Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists

enthalten in: Intensive care medicine | 2022

von Meynaar, I. | van Rijn, S. | Ottens, T. | +2

60

The use of corticosteroids in patients with COVID-19 vaccine–related cerebral venous thrombosis

enthalten in: Neurological sciences | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.